Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2801–2850 of 75328
appointed Zachary C. Lauer to serve as the Company’s Senior Vice President, Chief Operations Officer effective immediately.
the Board appointed Brian Burkavage, the Company’s current Senior Vice President, Finance, to serve as the Company’s principal financial officer and principal accounting officer, effective as of the Effective Time.
the Board of Directors (the “Board”) of Damora Therapeutics, Inc. (the “Company”) determined that, effective as of May 1, 2026 (the “Effective Time”), Lori Firmani would cease serving as the Company’s Chief Financial Officer.
On May 4, 2026, Adeia Inc. (the “Company” or “Adeia”) announced that Paul E. Davis, the Company’s chief executive officer, notified the Company and the Board of Directors (the “Board”) on May 4, 2026, of his intention to step down as the Company’s chief executive officer and as a member of the Board to focus on his health and personal pursuits.
On April 28, 2026, the Board of Directors of Madison Square Garden Sports Corp. (the "Company") appointed Paul DiCicco as Executive Vice President, Chief Financial Officer and Treasurer effective May 11, 2026 or such later date as may be agreed (the "Commencement Date").
Ms. Acosta will assume the responsibilities of principal accounting officer from Amrita Ahuja, who has been serving as interim principal accounting officer. Ms. Ahuja will continue in her roles as the Company’s Chief Financial Officer and Chief Operating Officer.
On April 30, 2026, the Board of Directors of Block, Inc. (the “Company”) appointed Andrea Acosta as the Company’s Chief Accounting Officer (principal accounting officer), effective as of May 26, 2026.
Effective as of April 29, 2026, the following individuals were appointed to the board of directors of the Company: Jean-Michel Enriquez Dahlhaus, and Hector Madero Rivero.
Effective as of April 29, 2026, the following individuals were appointed to the board of directors of the Company: Jean-Michel Enriquez Dahlhaus, and Hector Madero Rivero.
Additionally, the Board appointed John E. Stokely, Chair of the Board, as Executive Chair effective on May 4, 2026.
Mr. Arvan will also resign as a member of the Company’s Board of Directors (the “Board”), effective at the Transition Effective Time.
David G. Whalen will serve as lead independent director in the interim and receive a monthly fee of $5,000 for the period he serves in such role
The Board has appointed John B. Watwood as President and Chief Executive Officer, effective as of the Transition Effective Time.
On May 4, 2026, Pool Corporation (the “Company”), a Delaware corporation, and Peter D. Arvan mutually agreed that Mr. Arvan will cease to serve as President and Chief Executive Officer, effective May 4, 2026
Upon Mr. Reese's assumption of this role, Matt Kaplan, who was appointed President and Chief Executive Officer of the Company effective March 4, 2022, concluded his service as the Company's President and Chief Executive Officer.
On May 1, 2026, the Company's board of directors appointed Jason W. Reese to serve as the Company’s Chief Executive Officer effective immediately following the filing of the Company’s Form 10-Q for the period ended March 31, 2026.
On May 4, 2026, the Company's Board of Directors (the “Board”) appointed Mark A. Caylor as a Class II Director, effective immediately, to serve for a term expiring at the annual meeting of stockholders in 2029 and until his successor is elected and qualified.
Daniel Hoffman, Matthew Burns, James Shekerdemian and Francis Beaudette (the " New Directors ") were appointed to the board of directors of the Company
Samuel Sayegh was appointed as Chairman of the Company’s Board
Daniel Hoffman, Matthew Burns, James Shekerdemian and Francis Beaudette (the " New Directors ") were appointed to the board of directors of the Company
Daniel Hoffman, Matthew Burns, James Shekerdemian and Francis Beaudette (the " New Directors ") were appointed to the board of directors of the Company
Daniel Hoffman, Matthew Burns, James Shekerdemian and Francis Beaudette (the " New Directors ") were appointed to the board of directors of the Company
Under the Settlement Agreement, the Inscobee Parties have agreed to secure the resignation or removal of Mr. Koo.
Following Mr. Akright’s resignation, Eric Sherb, who has been serving as Co-Chief Financial Officer, will continue to serve as the Company’s Chief Financial Officer.
Effective as of April 28, 2026, Richard Akright advised the Company that he was resigning from his position as Co-Chief Financial Officer of urban-gro, Inc. (the “Company”), with such resignation becoming effective on such date.
On May 4, 2026, Pasithea Therapeutics Corp. (the “Company”) announced the appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer of the Company, effective May 1, 2026.
Seth H. Meyer, age 57, the Company's Chief Financial Officer since March 2019, will transition from his role as Chief Financial Officer and was appointed President of the Company.
Andrew Olson, age 43, was appointed Chief Financial Officer and Head of Corporate Development, succeeding Mr. Meyer in the role of Chief Financial Officer.
on May 4, 2026, following Mr. Barbieri's appointment as COO, Eddie Lazarus will no longer serve as the Company's Business Development Officer but will continue to serve as the Company's Chief Legal Officer.
On April 15, 2026, the Company appointed Frank Barbieri as Chief Operating Officer ("COO") and principal operating officer, effective as of May 4, 2026.
the Board of the Company appointed Jacob Saour as a member of the Board, effective immediately.
Karen Macleod and Peter Poli submitted their resignations as members of the Board of Directors of the Company
Karen Macleod and Peter Poli submitted their resignations as members of the Board of Directors of the Company
the Board of the Company appointed Denver Smith as a member of the Board, effective immediately.
the Board of the Company appointed Matthew Powalski as a member of the Board, effective immediately.
the Board of the Company appointed Kyle Kidd as a member of the Board, effective immediately.
On May 1, 2026, the Company’s board of directors appointed Lorenzo A. Flores, the Company’s Chief Financial Officer as Principal Accounting Officer of the Company.
On April 24, 2026, during a telephonic discussion with members of the Board of Directors (the “Board”) of Sentient Brands Holdings Inc. (the “Company”), George Furlan informed the Board of his resignation, effective April 24, 2026, from his positions as Interim Chief Executive Officer of the Company and as a member of the Board.
Effective May 1, 2026, and until such time as a new Chief Executive Officer is appointed, the Board designated Serge Knazev to serve as the Company’s acting principal executive officer for purposes of Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder, including the execution of certifications, attestations and other documents required to be signed by the principal executive officer in connection with the Company’s periodic and current reports filed under the Exchange Act.
On April 24, 2026, during a telephonic discussion with members of the Board of Directors (the “Board”) of Sentient Brands Holdings Inc. (the “Company”), George Furlan informed the Board of his resignation, effective April 24, 2026, from his positions as Interim Chief Executive Officer of the Company and as a member of the Board.
On April 28, 2026, the board of directors (the “Board”) of Streamex Corp. (the “Company”) appointed Mr. Mitchell Young Williams, the Company’s Chief Investment Officer, to serve as a non-independent director of the Board
the Board of Directors (the “Board”) of the Company appointed Laura C. Holson as the interim Chief Financial Officer and Treasurer of the Company, effective May 29, 2026.
Effective as of May 8, 2026, the Company's Board of Directors has appointed Julia Brau Donnelly, the Company's Chief Financial Officer, as principal accounting officer.
On April 30, 2026, Andrea Acosta, the Company's Chief Accounting Officer, submitted her resignation to the Company to pursue another opportunity, effective May 8, 2026.
On March 30, 2026, and in connection with the closing of the acquisition contemplated by the Purchase Agreement and the Board Election Agreement entered on April 1, 2026 (the “ Board Election Agreement ”), the Board of Directors of Parent appointed Steve Girardin as a Class III Director, effective as of the closing, with a term expiring at the annual stockholder meeting in 2029, and under certain circumstances if Steve Girardin leaves the Board prior to such annual meeting, to appoint Dave Girardin as his replacement through the 2029 annual meeting.
Mr. Bakas, who currently serves as President of Renewable Fuels of Ameresco will step down from this role at Ameresco and become the Chief Executive Officer of the Joint Venture.
On May 4, 2026, the Board of Directors (the "Board") of BARK, Inc. (the "Company") announced the appointment of James Gagne as a member of the Board, effective immediately, as a Class A director for a term expiring at the Company's 2028 annual meeting of stockholders and until his successor is duly elected and qualified.
approved the appointment of Paul Keel to fill the new director position, effective as of July 1, 2026
On May 4, 2026, after more than twenty years of service, Steve Odland informed the Company that he has decided not to stand for reelection to the Board of Directors at the Company’s 2026 Annual Meeting of Shareholders in September.
On April 13, 2026, Irving Minnaker resigned from the Board of Directors (the "Board") of Cycurion, Inc. (the "Company") and from any and all offices that he holds with the Company, effective as from February 14, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.